Featuring an interview with Dr Jonathan W Goldman, including the following topics:
- Contemporary and Future Care for Patients with Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:00)
- Evolving First-Line Treatment for Metastatic NSCLC with an EGFR Mutation (21:05)
- Other Emerging Strategies for Relapsed Metastatic Lung Cancer (29:16)
- Emerging Role of Antibody-Drug Conjugates in the Management of NSCLC with an EGFR Mutation (37:59)
- Current and Future Management of NSCLC with an EGFR Exon 20 Insertion Mutation (45:29)
CME information and select publications